Boehringer Ingelheim’s top-selling drug lifted sales in the first half, as the German drugmaker gears up to file for U.S. approval of a new obesity medicine. https://t.co/tcakKniBYn ...

The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly is losing to rival Novo Nordisk. https://t.co/GbmAU1tQVv ...

The market leader in obesity shots, Lilly hasn’t made a major dent in the pill market yet. https://t.co/nkkUEVXhpT ...